Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR+0.7%
5Y CAGR+33.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+0.7%/yr
Annual compound
5Y CAGR
+33.8%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$22.86M+10.2%
2024$20.74M-15.2%
2023$24.47M+9.4%
2022$22.37M+55.5%
2021$14.39M+169.9%
2020$5.33M+16.8%
2019$4.56M-